Sun Kim

Chief Executive Officer AIGENDRUG

Sun Kim is Chief Executive Officer of AIGENDRUG, an AI-powered drug discovery company dedicated to accelerating innovative therapeutics development. He is also a Professor in the Department of Computer Science and Engineering at Seoul National University and a recognized leader in bioinformatics and artificial intelligence for biomedical research. Dr. Kim previously served as Director of the Bioinformatics Institute at Seoul National University, held faculty leadership positions at Indiana University, and worked as a Senior Researcher at DuPont Central Research. He earned his Ph.D. in Computer Science from the University of Iowa and continues to advance the application of AI to transform drug discovery and development.

Seminars

Thursday 10th December 2026
DrugVLAB: Exploring Platform Technology Capabilities & Experimental Outputs to Discover Targets & Lead Candidates From Multi-Omics Data
9:00 am
  • Laying out the model building and development journey of DrugVLAB platform, trained and validated with extensive research paper insights
  • Applying AI platforms to decode multi-omics and compound data into target discovery, lead identification and optimization
  • Spotlighting case studies to demonstrate experimental validation of DrugVLAB outputs to assess the quality and reliability of AI-driven multi-omics drug discovery
Sun Kim